Appili Therapeutics

Insception Lifebank, located in Mississauga, Ontario, is Canada's largest and most experienced cord blood banking program, having assisted parents in preserving cord blood for over one million babies to date. With partnerships with leading medical and research institutions, Insception Lifebank emphasizes the importance of cord blood stem cells in treating over 80 life-threatening diseases. Committed to providing affordable and flexible options for families, Insception Lifebank hosts educational resources and parent engagement initiatives, helping them make informed decisions about cord blood and tissue banking. The organization showcases real-life testimonials of families whose lives have been positively impacted through the availability of stored cord blood stem cells. Generated from the website

CMX Research, based in Oakville, Canada, is a full-service Contract Research Organization (CRO) specializing in conducting clinical trials for drug and device studies. With over 32 years of experience, CMX offers expertise in a wide range of medical disciplines, including urology, oncology, immunology, cardiology, dermatology, endocrinology, and respirology. The company boasts a proven track record of successfully managing over 400 phase I-IV clinical trials globally, providing superior project management services such as ethics submissions, patient recruitment, and study closeout. Led by a practicing urologist and principal investigator, CMX Research is known for its proactive project planning, customized services, and access to a vast network of qualified investigators across Canada and the USA. Generated from their website

Innovative End-to-End Solutions for Phase 1 Clinical TrialsClinical trial complexity has strikingly escalated during the last decades, including a surge in the number of performed procedures, associated costs, and administrative load. Phase 1 clinical trials pose an especially significant challenge due to the requirements for extensive safety monitoring and correlative testing and the high failure rate of developmental drug candidates. BioPharma Services Inc. offers end-to-end solutions for Phase 1 clinical trials ranging from clinical trial design and execution to data reporting and tabulation and the preparation of a final Clinical Study Report. In addition, we have niche expertise in a number of study areas.